Roberto Rigoli
Impact in
- Sensory Systems top 5%
- Olfactory and Sensory Function Studies
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies
- Antimicrobial Resistance in Staphylococcus
- SARS-CoV-2 and COVID-19 Research
Papers in ⓘ
-
- COVID-19 Clinical Research Studies 4
- SARS-CoV-2 and COVID-19 Research 4
- Antimicrobial Resistance in Staphylococcus 3
- Epidemiology 10
- Infective Endocarditis Diagnosis and Management 3
- Co-authors
- Piergiorgio Scotton (6 shared papers)Francesco Rocco (3 shared papers)Elvio Polesel (3 shared papers)Zoran Olivari (3 shared papers)Fabio Chirillo (3 shared papers)Giuseppe Minniti (3 shared papers)Alessandra Pedrocco (2 shared papers)Jerry Polesel (3 shared papers)
- Journals
- The American Journal of Cardiology (2 papers)Gastroenterology (1 paper)Chemical Senses (1 paper)Clinical Chemistry and Laboratory Medicine (CCLM) (1 paper)Frontiers in Immunology (1 paper)
- Partner nations
- ItalyUnited KingdomArmenia
In The Last Decade
Roberto Rigoli
25 papers receiving 624 citations
Peers
Comparison fields: 5 of 90
- Sensory Systems 105
- Infectious Diseases 308
- Neurology 100
- Clinical Biochemistry 41
- Epidemiology 207
Countries citing papers authored by Roberto Rigoli
This map shows the geographic impact of Roberto Rigoli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Rigoli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Rigoli more than expected).
Fields of papers citing papers by Roberto Rigoli
This network shows the impact of papers produced by Roberto Rigoli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Rigoli. The network helps show where Roberto Rigoli may publish in the future.
Co-authors
The 25 scholars most cited alongside Roberto Rigoli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 114 | |
| 2 | 2021 | 92 | |
| 3 | 2020 | 64 | |
| 4 | 2020 | 55 | |
| 5 | 2021 | 40 | |
| 6 | 2014 | 39 | |
| 7 | 2012 | 29 | |
| 8 | 2017 | 23 | |
| 9 | 2019 | 22 | |
| 10 | 2011 | 19 | |
| 11 | 2021 | 16 | |
| 12 | 2020 | 14 | |
| 13 | 2019 | 14 | |
| 14 | 2019 | 14 | |
| 15 | 2013 | 13 | |
| 16 | 2018 | 13 | |
| 17 | 2021 | 12 | |
| 18 | 2013 | 11 | |
| 19 | 2019 | 7 | |
| 20 | 2014 | 5 |
About Roberto Rigoli
Roberto Rigoli is a scholar working on Infectious Diseases, Epidemiology, Public Health, Environmental and Occupational Health, Surgery and Clinical Biochemistry, having authored 25 papers that have together received 630 indexed citations. Recurring topics across this work include Bacterial Identification and Susceptibility Testing (4 papers), COVID-19 Clinical Research Studies (4 papers), SARS-CoV-2 and COVID-19 Research (4 papers), Infective Endocarditis Diagnosis and Management (3 papers), Streptococcal Infections and Treatments (3 papers), Antimicrobial Resistance in Staphylococcus (3 papers), Long-Term Effects of COVID-19 (2 papers) and Olfactory and Sensory Function Studies (2 papers). The work is most often cited by research in Sensory Systems (105 citations), Infectious Diseases (308 citations), Neurology (100 citations), Clinical Biochemistry (41 citations) and Epidemiology (207 citations). Roberto Rigoli has collaborated with scholars based in Italy, United Kingdom and Armenia. Frequent co-authors include Piergiorgio Scotton, Francesco Rocco, Elvio Polesel, Zoran Olivari, Fabio Chirillo, Giuseppe Minniti, Alessandra Pedrocco, Jerry Polesel, Daniele Borsetto and Giacomo Spinato. Their work appears in journals such as The American Journal of Cardiology, Gastroenterology, Chemical Senses, Clinical Chemistry and Laboratory Medicine (CCLM) and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.